Efficacy and Safety of a New 5% Minoxidil Formulation in Male Androgenetic Alopecia: A Randomized, Placebo-Controlled, Double-Blind, Noninferiority Study

    April 2018 in “ Journal of Cosmetic Dermatology ”
    Ulrike Blume-Peytavi, Zahida Issiakhem, Stéphanie Gautier … Jean-Jacques Voisard
    Studysummary This study found that the new minoxidil formulation, DC0120, was noninferior to the marketed product ALOSTIL® in promoting hair growth for men with androgenetic alopecia over 16 weeks.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 16

    1. Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men – Short Version Journal of The European Academy of Dermatology and Venereology · 2017
    2. Androgenetic Alopecia: A Review Endocrine · 2017
    3. A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men Skin Pharmacology and Physiology · 2015
    4. Androgenetic Alopecia: An Evidence-Based Treatment Update American Journal of Clinical Dermatology · 2014
    5. Quality of Life Assessment in Male Patients with Androgenetic Alopecia: Results of a Prospective, Multicenter Study Annals of Dermatology · 2012
    6. Analysis of Familial Factors Using the Basic and Specific (BASP) Classification in Korean Patients with Androgenetic Alopecia Journal of The American Academy of Dermatology · 2011
    7. S1 Guideline for Diagnostic Evaluation in Androgenetic Alopecia in Men, Women, and Adolescents British Journal of Dermatology · 2010
    8. Validation of TrichoScan Technology as a Fully-Automated Tool for Evaluation of Hair Growth Parameters European journal of dermatology/EJD. European journal of dermatology · 2009
    9. A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 2007
    10. Minoxidil: Mechanisms of Action on Hair Growth British Journal of Dermatology · 2004
    11. Genetic Basis of Male Pattern Baldness Journal of Investigative Dermatology · 2003
    12. Safety of Topical Minoxidil Solution: A One-Year, Prospective, Observational Study Journal of Cutaneous Medicine and Surgery · 2003
    13. A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 2002
    14. Histologic Response to Topically Applied Minoxidil in Male-Pattern Alopecia Clinics in Dermatology · 1988
    15. Androgenetic Alopecia Treated With Topical Minoxidil Journal of The American Academy of Dermatology · 1987
    16. Use of Topical Minoxidil in the Treatment of Male Pattern Baldness Journal of The American Academy of Dermatology · 1987

    Related research 7

    1. A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss PubMed · 2022
    2. Sisaipho Alopecia Areata Treated With Tofacitinib and Oral Minoxidil JAAD case reports · 2022
    3. Disorders of Hair DeckerMed Medicine · 2013
    4. Effect of Minoxidil on Hair Growth in Androgenic Alopecia in Women PubMed · 2002
    5. Use of Topical Minoxidil Therapy for Androgenetic Alopecia in Women International Journal of Dermatology · 1993
    6. Treatment of Female Androgenetic Alopecia with Minoxidil 2% International Journal of Dermatology · 1992
    7. Topical Minoxidil (3%) in Extensive Alopecia Areata, Including Long-Term Efficacy Journal of The American Academy of Dermatology · 1987